New Perspectives on Risk Stratification and Treatment in Patients with Atrial Fibrillation: An Analysis of Recent Contributions on the Journal of Cardiovascular Disease and Development

doi:10.3390/jcdd10020061

Editorial

. 2023 Feb 2;10(2):61.

doi: 10.3390/jcdd10020061.

New Perspectives on Risk Stratification and Treatment in Patients with Atrial Fibrillation: An Analysis of Recent Contributions on the Journal of Cardiovascular Disease and Development

Giuseppe Boriani¹, Niccolò Bonini^{1

2}, Jacopo Francesco Imberti^{1

2}, Marco Vitolo^{1

2}

Affiliations

¹ Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, 41124 Modena, Italy.
² Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, 41124 Modena, Italy.

PMID: 36826557
PMCID: PMC9965336
DOI: 10.3390/jcdd10020061

Editorial

New Perspectives on Risk Stratification and Treatment in Patients with Atrial Fibrillation: An Analysis of Recent Contributions on the Journal of Cardiovascular Disease and Development

Giuseppe Boriani et al. J Cardiovasc Dev Dis. 2023.

. 2023 Feb 2;10(2):61.

doi: 10.3390/jcdd10020061.

Authors

Giuseppe Boriani¹, Niccolò Bonini^{1

2}, Jacopo Francesco Imberti^{1

2}, Marco Vitolo^{1

2}

Affiliations

¹ Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, 41124 Modena, Italy.
² Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, 41124 Modena, Italy.

PMID: 36826557
PMCID: PMC9965336
DOI: 10.3390/jcdd10020061

Abstract

The medical approach to atrial fibrillation (AF) underwent a paradigm shift over time, evolving from considering AF as a simple arrhythmic phenomenon to a complex nosological entity [...].

PubMed Disclaimer

Conflict of interest statement

G.B. received small speaker fees from Bayer, Boston, Boehringer Ingelheim, Brystol Myers Squibb, Janssen and Sanofi outside of the submitted work. The other authors declare no conflicts of interest.

References

1. Boriani G., Vitolo M., Diemberger I., Proietti M., Valenti A.C., Malavasi V.L., Lip G.Y.H. Optimizing indices of atrial fibrillation suscep-tibility and burden to evaluate atrial fibrillation severity, risk and outcomes. Cardiovasc. Res. 2021;117:1–21. doi: 10.1093/cvr/cvab147. - DOI - PMC - PubMed
1. Deb B., Ganesan P., Feng R., Narayan S.M. Identifying Atrial Fibrillation Mechanisms for Personalized Medicine. J. Clin. Med. 2021;10:5679. doi: 10.3390/jcm10235679. - DOI - PMC - PubMed
1. Boriani G., Vitolo M., Lane D.A., Potpara T.S., Lip G.Y. Beyond the 2020 guidelines on atrial fibrillation of the European society of cardiology. Eur. J. Intern. Med. 2021;86:1–11. doi: 10.1016/j.ejim.2021.01.006. - DOI - PubMed
1. Proietti M., Romiti G.F., Vitolo M., Borgi M., Rocco A.D., Farcomeni A., Miyazawa K., Healey J.S., Lane D.A., Boriani G., et al. Epidemiology of subclinical atrial fibrillation in pa-tients with cardiac implantable electronic devices: A systematic review and meta-regression. Eur. J. Intern. Med. 2022;103:84–94. doi: 10.1016/j.ejim.2022.06.023. - DOI - PubMed
1. Freedman B., Camm J., Calkins H., Healey J.S., Rosenqvist M., Wang J., Albert C.M., Anderson C.S., Antoniou S., Benjamin E.J., et al. Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration. Circulation. 2017;135:1851–1867. doi: 10.1161/CIRCULATIONAHA.116.026693. - DOI - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources

[1] Boriani G., Vitolo M., Diemberger I., Proietti M., Valenti A.C., Malavasi V.L., Lip G.Y.H. Optimizing indices of atrial fibrillation suscep-tibility and burden to evaluate atrial fibrillation severity, risk and outcomes. Cardiovasc. Res. 2021;117:1–21. doi: 10.1093/cvr/cvab147. - DOI - PMC - PubMed

[2] Boriani G., Vitolo M., Diemberger I., Proietti M., Valenti A.C., Malavasi V.L., Lip G.Y.H. Optimizing indices of atrial fibrillation suscep-tibility and burden to evaluate atrial fibrillation severity, risk and outcomes. Cardiovasc. Res. 2021;117:1–21. doi: 10.1093/cvr/cvab147. - DOI - PMC - PubMed

[3] Deb B., Ganesan P., Feng R., Narayan S.M. Identifying Atrial Fibrillation Mechanisms for Personalized Medicine. J. Clin. Med. 2021;10:5679. doi: 10.3390/jcm10235679. - DOI - PMC - PubMed

[4] Deb B., Ganesan P., Feng R., Narayan S.M. Identifying Atrial Fibrillation Mechanisms for Personalized Medicine. J. Clin. Med. 2021;10:5679. doi: 10.3390/jcm10235679. - DOI - PMC - PubMed

[5] Boriani G., Vitolo M., Lane D.A., Potpara T.S., Lip G.Y. Beyond the 2020 guidelines on atrial fibrillation of the European society of cardiology. Eur. J. Intern. Med. 2021;86:1–11. doi: 10.1016/j.ejim.2021.01.006. - DOI - PubMed

[6] Boriani G., Vitolo M., Lane D.A., Potpara T.S., Lip G.Y. Beyond the 2020 guidelines on atrial fibrillation of the European society of cardiology. Eur. J. Intern. Med. 2021;86:1–11. doi: 10.1016/j.ejim.2021.01.006. - DOI - PubMed

[7] Proietti M., Romiti G.F., Vitolo M., Borgi M., Rocco A.D., Farcomeni A., Miyazawa K., Healey J.S., Lane D.A., Boriani G., et al. Epidemiology of subclinical atrial fibrillation in pa-tients with cardiac implantable electronic devices: A systematic review and meta-regression. Eur. J. Intern. Med. 2022;103:84–94. doi: 10.1016/j.ejim.2022.06.023. - DOI - PubMed

[8] Proietti M., Romiti G.F., Vitolo M., Borgi M., Rocco A.D., Farcomeni A., Miyazawa K., Healey J.S., Lane D.A., Boriani G., et al. Epidemiology of subclinical atrial fibrillation in pa-tients with cardiac implantable electronic devices: A systematic review and meta-regression. Eur. J. Intern. Med. 2022;103:84–94. doi: 10.1016/j.ejim.2022.06.023. - DOI - PubMed

[9] Freedman B., Camm J., Calkins H., Healey J.S., Rosenqvist M., Wang J., Albert C.M., Anderson C.S., Antoniou S., Benjamin E.J., et al. Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration. Circulation. 2017;135:1851–1867. doi: 10.1161/CIRCULATIONAHA.116.026693. - DOI - PubMed

[10] Freedman B., Camm J., Calkins H., Healey J.S., Rosenqvist M., Wang J., Albert C.M., Anderson C.S., Antoniou S., Benjamin E.J., et al. Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration. Circulation. 2017;135:1851–1867. doi: 10.1161/CIRCULATIONAHA.116.026693. - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

New Perspectives on Risk Stratification and Treatment in Patients with Atrial Fibrillation: An Analysis of Recent Contributions on the Journal of Cardiovascular Disease and Development

Affiliations

New Perspectives on Risk Stratification and Treatment in Patients with Atrial Fibrillation: An Analysis of Recent Contributions on the Journal of Cardiovascular Disease and Development

Authors

Affiliations

Abstract

Conflict of interest statement

Similar articles

References

Publication types

LinkOut - more resources

Full Text Sources

Abstract

Conflict of interest statement

Similar articles

References

Publication types

Related information

LinkOut - more resources

Full Text Sources